Shanghai Institute of Materia Medica Chooses Provantis Software Solution
Provantis Software-as-a-Service Model Chosen by Leading Shanghai-Based Drug Development Institute
CONSHOHOCKEN, PA - (BUSINESS WIRE) –October 6, 2010 - - Instem, a leading provider of early development software applications, announced today that the Shanghai Institute of Materia Medica (SIMM) has purchased an online subscription to the Provantis® preclinical software solution suite. SIMM will be using a range of Provantis modules across the areas of general toxicology, clinical pathology and pathology as part of their wider strategy to automate scientific processes to help bring more medical breakthroughs to the People’s Republic of China.
SIMM, part of the Chinese Academy of Sciences, ranks at the top in China for its drug discovery and development activities with more than 70 drugs having been developed since its establishment. The major research directions of SIMM include drugs for diseases seriously endangering the health of the Chinese population, such as tumors as well as, cardiovascular, neurological, metabolic, autoimmune and infectious diseases.
As the overwhelming standard in western facilities, Provantis is a modern preclinical research technology solution that is easy to use and will offer SIMM compliance to national and western standards, dual language operation and proven protocol-driven automation that will produce high quality study output in greatly reduced timescales.
“As the primary participant in the newly established Research Center for Modernization of Traditional Chinese Medicine, we are honored that SIMM has chosen Instem’s Provantis software to automate their research laboratories,” comments Phil Reason, CEO at Instem. “SIMM is one of the leading interdisciplinary research centers in China, and recognized worldwide by its outstanding achievements in both basic and applied research fields. We are looking forward to closely working with their staff so they can quickly realize the benefits of Provantis and continue their excellent scientific contributions.”
SIMM will be using Instem’s SaaS (Software-as-a-Service) model offering simpler, more cost effective ways to provide software functionality, maintenance, and support over the Internet. Since 2005, Instem has utilized state of the art data centers, which are being used by clients running GLP and non-GLP studies.
Specifically for Asia-Pacific organizations seeking to reduce the costs and complexity of their on-site technical footprints, Instem offers a localized online access point to its Provantis preclinical application. Their Shanghai-based data center meets the highest standards for reliability, security and redundancy and is managed by experienced staff 365 days a year. Strategically located in PuDong, this purpose built data center features a state-of-the-art network, power and environmental infrastructure and is ISO 9001 and SunTone™ certified.
“SIMM’s decision to purchase was strongly endorsed by other leading organizations and government laboratories,” comments Neil Donaldson, Instem’s VP of European and Asian operations. “We encourage each of our prospective clients to interact with existing Provantis users, but it is not just to discover the benefits of our technology. By speaking directly to clients, they can hear first-hand how responsive our staff is and how as an organization we become a cost effective extension of their business.”
Instem in the People’s Republic of China (PRC)
As the first western toxicology/pathology software supplier to enter the Chinese market, Instem officially deployed its first China-based system in one of the largest and most advanced vivariums during 2006.
Understanding that by 2014 the PRC would be the second largest pharmaceutical market in the world; Instem established a full-service office in Shanghai, recruited local staff and has localized the Provantis product suite into Mandarin Chinese. Instem is supporting both international organizations and domestic laboratories exclusively serving the PRC.
About Provantis®
Provantis is a modern, fully integrated software system for single users and global organizations engaged in preclinical evaluation studies. Orchestrating every facet of preclinical drug safety assessment, Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple or complex studies within a GLP or non-GLP environment, on-site or over the Web.
About SIMM
The Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences (CAS), evolved from the Institute of Materia Medica of Peking Academy of Sciences founded in 1932. Its current location is within the heart of Zhang Jiang Hi-Tech Park, Pudong New District.
SIMM’s mission is to provide a comprehensive solution in drug discovery and development. By combining basic and applied research efforts and through cross-fostering between chemistry and biology, scientists at SIMM carry out studies toward the elucidation of the structural basis of bioactive substances, discovery of new targets or mechanisms of action, comprehensive pre-clinical evaluation of drug candidates, and promotion of commercialization, thereby playing an indispensable role in building China’s drug innovation capabilities.
About Instem
Instem is a leading supplier of IT applications to the early development healthcare market, delivering compelling solutions for data collection, management and analysis across the R&D continuum. Instem applications are in use by customers worldwide, meeting the rapidly expanding needs of life science and healthcare organizations for data-driven decision making leading to safer, more effective products.
Instem’s portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonization of actionable scientific information.
Instem supports over 400 clients through full service offices in the United States, United Kingdom and China with additional locations in India and a full service distributor based in Japan.
Meeting clients at the intersection of investment & return™.
Press Contacts:
Instem
Gary Mitchell (US HQ)
gary.mitchell@instem.com
Tel: 610-941-0990
Julie Jones (UK HQ)
julie.jones@instem.com
Tel: +44 (0) 1785 825600
